A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2001
11/15/2001	US20010041786 Stabilized acylated insulin formulations
11/15/2001	US20010041743 Prostaglandins
11/15/2001	US20010041727 Use of pramipexole for the treatment of addictive disorders
11/15/2001	US20010041721 Beta blocker and a C3-C7 fatty acid or salt thereof; carteolol hydrochloride and sorbic acid for example; promotes penetration of beta-blocker into the eye
11/15/2001	US20010041717 Chronic, bolus administration of D-threo methylphenidate
11/15/2001	US20010041697 Implanting in an animal an effective amount of melengestrol acetate and trenbolone acetate for increasing growth performance, suppressing estrus and preventing pregnancy in an animal prefererably heifer
11/15/2001	US20010041695 Orally administering to a post-menopausal woman a fat soluble vitamin and a fat soluble vitamin absorption increasing effective amount of L-carnitine or salts
11/15/2001	US20010041685 Mucin synthesis inhibitors
11/15/2001	US20010041684 Topical wound therapeutic compositions
11/15/2001	US20010041682 Purine or pyrimidine containing dinucleotide derivatives useful for hydrating mucous secretions in the lungs of a patient in need of such a treatment
11/15/2001	US20010041671 Ophthalmic formulations
11/15/2001	US20010041190 Breathing mixture of drug and carrier powder
11/15/2001	US20010041189 Dipeptide containing glutamic acid
11/15/2001	US20010041186 Composition and method for acceleration of wound and burn healing
11/15/2001	US20010041182 Stable activity antioxidant provitamin such as l-ascorbic acid-2-phosphate and alpha-tocopheryl phosphate
11/15/2001	US20010041178 Preventing airway mucus production by administration of EGF-R antagonists
11/15/2001	US20010041166 The sheet pressure-sensitive adhesive layer containing a medicine; water insolubility; surface anesthesia, dentistry
11/15/2001	US20010041165 Effervescent bisphosphonate formulation
11/15/2001	US20010041164 Pharmaceutical preparation for inhalation of an opioid
11/15/2001	DE10100445A1 Treating digestive disorders, excessive mucus formation in upper respiratory tract and/or hemorrhoids, by topical application of analgesic to acupuncture points of the hand
11/15/2001	DE10045904A1 Retard alpha-lipoic acid composition based on cationogenic polymer carrier, especially chitosan, useful as a food supplement, medicament or cosmetic
11/15/2001	DE10021618A1 Drug preparation or foodstuff for treating inflammatory bowel disease or pouchitis in colectomy patients, contains 4-aminoacyloxyalkyl-2-oxetanone derivative such as orlistat
11/15/2001	CA2691739A1 Stabilized formulations of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo [b]thiophene and salts thereof
11/15/2001	CA2409461A1 Evaporative coolant comprising hydrofluorocarbons and/or hydrochlorofluorocarbons
11/15/2001	CA2408647A1 Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
11/15/2001	CA2408571A1 Mammalian receptor proteins; related reagents and methods
11/15/2001	CA2408563A1 Stabilized formulations of 6-hydroxy-3-(4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene and salts thereof
11/15/2001	CA2408464A1 Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
11/15/2001	CA2408352A1 Nontoxic vernix compositions and method of producing
11/15/2001	CA2408152A1 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy
11/15/2001	CA2408112A1 Skin protectant spray compositions
11/15/2001	CA2408106A1 Opioid antagonist compositions and dosage forms
11/15/2001	CA2408098A1 Opioid antagonist containing composition for enhancing the potency or reducing adverse side effects of opioid agonists
11/15/2001	CA2395314A1 Compounds and methods for modulating cerebral amyloid angiopathy
11/14/2001	EP1153960A1 Process for producing a solid shaped form from low DE starch hydrolysates and/or coated with these starch hydrolysates
11/14/2001	EP1153940A1 Polymer combining with phosphoric acid and preparation containing the same
11/14/2001	EP1153931A1 Shortened-chain polynucleotides and process for the preparation thereof
11/14/2001	EP1153624A1 Portable pain relieving device
11/14/2001	EP1153616A1 Tablets quickly disintegrated in the oral cavity
11/14/2001	EP1153615A1 Pharmaceutical formulation for intravenous or intramuscular octreotide administration
11/14/2001	EP1153614A1 Ophthalmic compositions
11/14/2001	EP1153613A1 Percutaneous absorption preparations of compound having angiotensin ii receptor antagonism
11/14/2001	EP1153605A1 Proanthocyanidins and ascorbic acid composition for topical application to human respiratory and oral mucosa
11/14/2001	EP1153602A1 Skin preparations for external use
11/14/2001	EP1153601A1 Skin preparations for external use
11/14/2001	EP1153129A1 Method of treating restenosis by antisense targeting of c-myc
11/14/2001	EP1152776A1 Biodegradable, injectable oligomer-polymer composition
11/14/2001	EP1152774A2 Biocompatible material with a novel functionality
11/14/2001	EP1152772A2 Liposome composition and method for administration of a radiosensitizer
11/14/2001	EP1152763A2 Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence
11/14/2001	EP1152762A1 Use of desoxypeganine in the treatment of alzheimer's dementia
11/14/2001	EP1152753A1 Combinations of formoterol and fluticasone propionate for asthma
11/14/2001	EP1152751A1 Desoxypeganine transdermal therapeutic system
11/14/2001	EP1152750A1 Spontaneously dispersible n-benzoyl staurosporine compositions
11/14/2001	EP1152749A2 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
11/14/2001	EP1152748A1 Method and composition for treating acne
11/14/2001	EP1152744A1 Skin sanitizing compositions
11/14/2001	EP1152743A1 Skin sanitizing compositions
11/14/2001	EP1152731A1 A skin care composition that mediates cell to cell communication
11/14/2001	EP1152723A1 Enzymatic treatment and prevention of hypertrophic skin
11/14/2001	EP1152709A1 Controlled release composite
11/14/2001	EP1125575A9 Perfusate preparation for ophthalmic operation
11/14/2001	EP1117720A4 Polyester analogue of poly-l-lysine as a soluble, biodegradable gene delivery carrier
11/14/2001	EP1066380B1 Soluble t cell receptor
11/14/2001	EP1061938B1 Oral compositions at low dosage of cytotoxic proteins
11/14/2001	EP1003484B1 Improved multiparticulate tablet with quick disintegration
11/14/2001	EP1001745B1 Artificial tear formulation
11/14/2001	EP0980250B1 Plant extracts for the treatment of increased bone resorption
11/14/2001	EP0971879B1 Solid compositions suitable for oral administration comprising l-carnitine and alkanoyl-l-carnitine magnesium tartrate
11/14/2001	EP0946152B1 Biodegradable capsule with a prolamin base
11/14/2001	EP0923942B1 5alpha-REDUCTASE INHIBITORY PREPARATION FOR ORAL ADMINISTRATION, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF
11/14/2001	EP0922071B1 Polycarboxylic based cross-linked copolymers
11/14/2001	EP0904081B1 Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
11/14/2001	EP0825882B1 Medical device adhering to the skin
11/14/2001	EP0804170B1 Method for making freeze dried drug dosage forms
11/14/2001	EP0799052B1 New antithrombotic formulation, process for its manufacturing, and use thereof
11/14/2001	EP0762883B1 Pyridylbisphosphonates for use as a therapeutical agent
11/14/2001	EP0760648B1 Chewable flubendazole tablets for companion animals
11/14/2001	CN1322210A High purity composition comprising (7a, 17a,)-17-hydroxy-7-methyl 19-nor-17-prege-5-(10)-en-20-yn-3-one
11/14/2001	CN1322138A Protease inhibitors for use in treatment of psoriasis
11/14/2001	CN1322131A Nimesulide containing topical pharmaceutical compositions
11/14/2001	CN1322129A Electrically controlled transport of charged penetrants across barriers
11/14/2001	CN1321746A Human insuline recombinant gene, preparation method and application
11/14/2001	CN1321515A Buccal lozenge for preventing dental caries and its production method
11/14/2001	CN1321507A Chinese medicine for curing rheumatoid disease and preparing method thereof
11/14/2001	CN1321485A Lintongtie plaster and its preparation method
11/14/2001	CN1321475A Chinese medicine gel powder
11/14/2001	CN1321462A Oral liquor capable of preventing dental caries and relieving inflammation
11/14/2001	CN1321421A Macromolecular coating powder for solid medicine preparation and its preparation method
11/14/2001	CN1074762C Process for preparing chromium L-threonate, its preparing process and application
11/14/2001	CN1074678C Preparation method of external-applied chinese herbal medicine plaster for treating hepatitis B
11/14/2001	CN1074673C Freeze-dried kakonein powder injection and preparing method thereof
11/14/2001	CN1074672C Method for preparing fermented soya beans and ginger injection
11/14/2001	CN1074669C Kidney-nourishing and bone-strengthening pill and its preparation
11/14/2001	CN1074660C Use of bilayer forming emulsifiers in nutritional compositions comprising divalent metal salts
11/13/2001	US6316598 Oxidizing insoluble keratin in soluble oxidizing agent, such that a portion of disulfide bonds of are oxidized to form sulfonic acid residues, to obtain an oxidized insoluble solid fraction; separating; forming salt suspension; removing
11/13/2001	US6316581 Bioresorbable copolymers
11/13/2001	US6316522 Bioresorbable hydrogel compositions for implantable prostheses
11/13/2001	US6316505 For side effect reduction, transport of the drug to solid tumors and a reverse multiple drug resistance
11/13/2001	US6316501 Methods of inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general

1 ... 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 2363 2364 ... 2991